. 2022 Dec 1;13:1035418. doi: 10.3389/fendo.2022.1035418

Table 3.

The calculation values of indexes for MAFLD and its subgroups.

	Overall (n =1058)		Obesity (n =708)		Lean (n =188)		T₂DM (n =162)
Indicators	MAFLD (n =621)	Non-MAFLD (n =437)	MAFLD (n =464)	Non-MAFLD (n =244)	MAFLD (n =36)	Non-MAFLD (n =152)	MAFLD (n =121)	Non-MAFLD (n =41)
BMI	29.29 ± 4.87	24.20 ± 3.09 ^*	28.47 ± 2.90	26.13 ± 2.19 ^*	22.68 ± 0.35	21.04 ± 1.42 ^*	34.39 ± 6.93	24.41 ± 2.66 ^*
AI1	3.25 ± 0.99	2.49 ± 0.88 ^*	3.20 ± 0.95	2.67 ± 0.89 ^*	2.97 ± 1.08	2.17 ± 0.78 ^*	3.53 ± 1.06	2.62 ± 0.91 ^*
AI2	2.56 ± 0.80	2.03 ± 0.72 ^*	2.56 ± 0.78	2.20 ± 0.74 ^*	2.43 ± 0.98	1.79 ± 0.64 ^*	2.61 ± 0.84	1.91 ± 0.68 ^*
non-HDL-C	3.67 ± 0.86	3.21 ± 0.85 ^*	3.63 ± 0.84	3.27 ± 0.81 ^*	3.67 ± 1.08	3.06 ± 0.87 ^*	3.82 ± 0.86	3.42 ± 1.00 ^*
R-CHR	4.25 ± 0.99	3.49 ± 0.88 ^*	4.20 ± 0.95	3.67 ± 0.89 ^*	3.97 ± 1.08	3.17 ± 0.78 ^*	4.53 ± 1.06	3.62 ± 0.91 ^*
AIP	0.24 ± 0.26	-0.09 ± 0.28 ^*	0.21 ± 0.26	-0.02 ± 0.27 ^*	0.18 ± 0.24	-0.22 ± 0.24 ^*	0.35 ± 0.23	-0.06 ± 0.30 ^*
LCI	30.75 ± 23.67	13.27 ± 13.18 ^*	29.03 ± 23.17	15.33 ± 13.42 ^*	27.87 ± 22.21	9.34 ± 8.99 ^*	38.20 ± 24.68	15.59 ± 20.12 ^*
BLCI1	0.37 ± 0.15	0.34 ± 0.14 ^*	0.37 ± 0.15	0.34 ± 0.14 ^*	0.44 ± 0.17	0.34 ± 0.14 ^*	0.36 ± 0.16	0.33 ± 0.13
BLCI2	0.22 ± 0.10	0.20 ± 0.09 ^*	0.22 ± 0.10	0.20 ± 0.09 ^*	0.26 ± 0.12	0.19 ± 0.09 ^*	0.21 ± 0.10	0.17 ± 0.08
TG/HDL-C	2.06 ± 1.25	1.00 ± 0.78 ^*	1.94 ± 1.21	1.16 ± 0.85 ^*	1.79 ± 1.13	0.71 ± 0.44 ^*	2.58 ± 1.34	1.14 ± 1.00 ^*
BAI	31.38 ± 6.54	26.38 ± 4.21 ^*	30.94 ± 6.32	26.89 ± 4.11 ^*	28.79 ± 7.55	25.59 ± 4.52 ^*	33.87 ± 6.43	26.20 ± 3.04 ^*
BRI	5.18 ± 1.67	3.46 ± 1.01 ^*	4.80 ± 1.10	3.90 ± 0.87 ^*	4.04 ± 1.22	2.67 ± 0.78 ^*	6.98 ± 2.25	3.76 ± 0.72 ^*
LAP	92.37 ± 90.87	30.56 ± 30.64 ^*	76.42 ± 59.25	38.75 ± 35.26 ^*	66.15 ± 53.04	16.32 ± 12.42 ^*	161.34 ± 149.37	34.62 ± 30.01 ^*
VAI	3.07 ± 1.90	1.44 ± 1.05 ^*	2.80 ± 1.72	1.63 ± 1.14 ^*	3.23 ± 2.17	1.10 ± 0.67 ^*	4.08 ± 2.12	1.57 ± 1.29 ^*
WTI	246.43 ± 220.71	108.78 ± 84.09 ^*	217.66 ± 160.22	126.80 ± 95.40 ^*	203.44 ± 157.54	75.87 ± 40.21 ^*	369.54 ± 355.49	123.54 ± 96.70 ^*
WWI	10.82 ± 0.80	10.22 ± 0.73 ^*	10.68 ± 0.71	10.29 ± 0.65 ^*	11.18 ± 1.18	10.02 ± 0.84 ^*	11.28 ± 0.78	10.53 ± 0.46 ^*
CVAI	142.55 ± 47.80	78.04 ± 45.61 ^*	134.80 ± 35.49	96.84 ± 38.44 ^*	95.28 ± 23.38	39.54 ± 33.33 ^*	186.32 ± 62.85	108.93 ± 27.03 ^*
FLI	10.05 ± 17.11	1.16 ± 2.36 ^*	5.99 ± 7.86	1.75 ± 2.93 ^*	1.11 ± 0.93	0.20 ± 0.25 ^*	28.24 ± 29.20	1.17 ± 1.64 ^*
ZJU index	43.35 ± 7.10	35.01 ± 4.20 ^*	41.62 ± 4.21	37.10 ± 3.22 ^*	35.69 ± 1.98	31.04 ± 2.17 ^*	52.26 ± 9.05	37.24 ± 4.45 ^*
TyG index	1.80 ± 0.70	1.04 ± 0.58 ^*	1.66 ± 0.59	1.13 ± 0.55 ^*	1.67 ± 0.51	0.79 ± 0.48 ^*	2.40 ± 0.83	1.44 ± 0.70 ^*
FLDI	37.14 ± 6.36	29.12 ± 4.30 ^*	35.94 ± 4.20	31.47 ± 3.28 ^*	29.35 ± 1.94	24.95 ± 2.25 ^*	44.08 ± 8.22	30.59 ± 3.84 ^*
CMI	1.21 ± 0.79	0.52 ± 0.43 ^*	1.11 ± 0.71	0.62 ± 0.48 ^*	0.95 ± 0.60	0.33 ± 0.21 ^*	1.70 ± 0.92	0.60 ± 0.55 ^*

Data were expressed as mean ± standard deviation ( $\bar{x} \pm s$ ) and analyzed by student’s t-test for continuous variables.

compared with MAFLD in respective subgroups, ^*P < 0.05.

MAFLD, metabolic dysfunction-associated fatty liver disease; T₂DM, type 2 diabetes mellitus; BMI, body mass index; AI, atherosclerosis index; HDL-C, high-density lipoprotein cholesterol; R-CHR, coronary heart index; AIP, atherogenic index of plasma; LCI: lipid comprehensive index; BLCI, bilirubin lipid composite index; TG, triglyceride; BAI, body adiposity index; BRI, body roundness index; LAP, lipid accumulation product; VAI, visceral fat index; WTI, waist triglyceride index; WWI, weight-adjusted waist index; CVAI, Chinese visceral adiposity index; FLI, fatty liver index; ZJU index, Zhejiang University index; TyG index, triglyceride-glucose index; FLDI, fatty liver disease index; CMI, cardiometabolic index.